Breaking Bad: Kevin Caldwell and Ossium Health is banking on bone marrow for curing cancers and transforming regenerative care

Breaking Precedent

In this episode of Breaking Precedent, host Leah Solivan sits down with Kevin Caldwell, founder and CEO of Ossium Health. From blending astrophysics, economics, and law, Kevin's unconventional journey to biotech is as inspiring as it is innovative. Kevin shares his groundbreaking work in making stem cell therapies more accessible, the future of preventative medicine, and the immense impact Ossium could have on treating blood cancers and beyond. Kevin shares his vision for a healthier world, leveraging cutting-edge science to save lives and improve health spans.

Guest Bio and Links:

As CEO, Co-Founder & President of Ossium Health, Kevin Caldwell has built Ossium from a small startup into a clinical-stage bioengineering company. Kevin set the company’s mission to improve human health through bioengineering and designed its platform-based model for cellular therapeutics development. Kevin has led the company’s successful pursuit, negotiation, and execution of more than 50 business relationships, including 5 successful fundraisings and dozens of supply partnerships, clinical partnerships, and commercial contracts with biopharmaceutical companies.

Listeners can learn more about Kevin Caldwell at Ossium Health

Show Notes:

• (0:30) Leah introduces guest, Kevin Caldwell, founder and CEO of Ossium Health
• (4:00) Kevin's unconventional journey
• (5:00) Childhood curiosity and influences
• (13:00) MIT and the love for science
• (16:30) From physics to law
• (23:00) Time at Bridgewater
• (25:00) The role of cross-disciplinary thinking in Kevin’s career
• (33:30) “Our healthcare system was very reactive, like first they would get sick, and then we would take them to see a doctor who would retroactively diagnose them and prescribe an intervention that usually did reduce their suffering but didn't really improve their health.”
• (34:00) The economics in healthcare
• (36:30) Meeting the co-founder and starting Ossium
• (39:00) The vision and technology behind Ossium
• (49:00) The future of preventative medicine and stem cell banking
• (53:00) The first successful transplant using Ossium's technology
• (56:30) The role of venture investors
• (1:03:00) Final thoughts

---

Leah Solivan is the host of Breaking Precedent, a podcast that explores the stories of innovators who are pushing societal boundaries and setting new precedents in their fields. Leah is General Partner at Fuel Capital, where she invests in early-stage companies across consumer technology, hardware, education, marketplaces, and retail. Leah has 15 years of experience building and creating technology products that have reached millions of people around the globe. She started her career at IBM as an engineer in the software group, working on Lotus Notes and Domino. In 2008, Leah founded TaskRabbit, the leading on-demand service marketplace in the world.

Connect with Leah:

Website: breakingprecedent.com/

Instagram: @labunleashed

X: @labunleashed